360 related articles for article (PubMed ID: 1721976)
1. Comparison of the effects of carvedilol, propranolol, and verapamil on in vitro platelet function in healthy volunteers.
Gasser JA; Betterridge DJ
J Cardiovasc Pharmacol; 1991; 18 Suppl 4():S29-34. PubMed ID: 1721976
[TBL] [Abstract][Full Text] [Related]
2. Carvedilol--a beta-blocker with considerable antiaggregatory effect on human blood platelets.
Petrikova M; Jancinova V; Nosal R; Majekova M; Fabryova V
Bratisl Lek Listy; 2005; 106(1):20-5. PubMed ID: 15869009
[TBL] [Abstract][Full Text] [Related]
3. Inhibition of platelet function of antiarrhythmic drugs, verapamil and disopyramide.
Han P; Boatwright C; Ardlie NG
Thromb Haemost; 1982 Apr; 47(2):150-3. PubMed ID: 7101234
[TBL] [Abstract][Full Text] [Related]
4. Effect of the calcium-entry blocking agent nifedipine on activation of human platelets and comparison with verapamil.
Han P; Boatwright C; Ardlie NG
Thromb Haemost; 1983 Aug; 50(2):513-7. PubMed ID: 6314581
[TBL] [Abstract][Full Text] [Related]
5. Antiplatelet activity of carvedilol in comparison to propranolol.
Petríková M; Jancinová V; Nosál R; Májeková M; Danihelová E
Platelets; 2002 Dec; 13(8):479-85. PubMed ID: 12487781
[TBL] [Abstract][Full Text] [Related]
6. Effects of nebivolol on human platelet aggregation.
Falciani M; Rinaldi B; D'Agostino B; Mazzeo F; Rossi S; Nobili B; Rossi F; Filippelli A
J Cardiovasc Pharmacol; 2001 Dec; 38(6):922-9. PubMed ID: 11707696
[TBL] [Abstract][Full Text] [Related]
7. Effects of long-acting propranolol and verapamil on blood pressure, platelet function, metabolic and rheological properties in hypertension.
Ding YA; Chou TC; Lin KC
J Hum Hypertens; 1994 Apr; 8(4):273-8. PubMed ID: 8021907
[TBL] [Abstract][Full Text] [Related]
8. Disparate effects of the calcium-channel blockers, nifedipine and verapamil, on alpha 2-adrenergic receptors and thromboxane A2-induced aggregation of human platelets.
Johnson GJ; Leis LA; Francis GS
Circulation; 1986 Apr; 73(4):847-54. PubMed ID: 3004784
[TBL] [Abstract][Full Text] [Related]
9. Effects of bupranolol, a new beta-blocker, on platelet functions of rabbit and human in vitro.
Umetsu T; Sanai K; Kato T
Thromb Haemost; 1976 Nov; 36(2):376-87. PubMed ID: 12593
[TBL] [Abstract][Full Text] [Related]
10. A new insight of anti-platelet effects of sirtinol in platelets aggregation via cyclic AMP phosphodiesterase.
Liu FC; Liao CH; Chang YW; Liou JT; Day YJ
Biochem Pharmacol; 2009 Apr; 77(8):1364-73. PubMed ID: 19426675
[TBL] [Abstract][Full Text] [Related]
11. [The role of prostaglandins in the effect of beta-blockers on stimulated blood platelets].
Nosál' R; Jancinová V; Petríková M
Vnitr Lek; 1991 Mar; 37(3):261-7. PubMed ID: 1674390
[TBL] [Abstract][Full Text] [Related]
12. A comparative study of the effects of adrenoceptor antagonists on platelet aggregation and thromboxane generation.
Greer IA; Walker JJ; McLaren M; Calder AA; Forbes CD
Thromb Haemost; 1985 Aug; 54(2):480-4. PubMed ID: 2867620
[TBL] [Abstract][Full Text] [Related]
13. Beta-adrenoceptor antagonists and human platelets: relationship of effects to lipid solubility.
Kerry R; Scrutton MC; Wallis RB
Biochem Pharmacol; 1984 Aug; 33(16):2615-22. PubMed ID: 6147145
[TBL] [Abstract][Full Text] [Related]
14. Inhibition of human platelet functions by verapamil.
Ikeda Y; Kikuchi M; Toyama K; Watanabe K; Ando Y
Thromb Haemost; 1981 Apr; 45(2):158-61. PubMed ID: 6789494
[TBL] [Abstract][Full Text] [Related]
15. Effects of propranolol in vitro and in vivo on platelet function and thromboxane formation in normal volunteers.
Siess W; Lorenz R; Roth P; Weber PC
Agents Actions; 1983 Feb; 13(1):29-34. PubMed ID: 6344593
[TBL] [Abstract][Full Text] [Related]
16. Licofelone, an inhibitor of cyclooxygenase and 5-lipoxygenase, specifically inhibits cyclooxygenase-1-dependent platelet activation.
Rotondo S; Krauze-Brzósko K; Manarini S; Evangelista V; Cerletti C
Eur J Pharmacol; 2004 Mar; 488(1-3):79-83. PubMed ID: 15044038
[TBL] [Abstract][Full Text] [Related]
17. Verapamil and collagen-induced platelet reactions--evidence for a role for intracellular calcium in platelet activation.
Han P; Boatwright C; Ardlie NG
Thromb Haemost; 1983 Aug; 50(2):537-40. PubMed ID: 6415847
[TBL] [Abstract][Full Text] [Related]
18. Carvedilol, a new vasodilator and beta adrenoceptor antagonist, is an antioxidant and free radical scavenger.
Yue TL; Cheng HY; Lysko PG; McKenna PJ; Feuerstein R; Gu JL; Lysko KA; Davis LL; Feuerstein G
J Pharmacol Exp Ther; 1992 Oct; 263(1):92-8. PubMed ID: 1357162
[TBL] [Abstract][Full Text] [Related]
19. ADP-mimicking platelet aggregation caused by rugosin E, an ellagitannin isolated from Rosa rugosa Thunb.
Teng CM; Kang YF; Chang YL; Ko FN; Yang SC; Hsu FL
Thromb Haemost; 1997 Mar; 77(3):555-61. PubMed ID: 9066010
[TBL] [Abstract][Full Text] [Related]
20. Effects of alpha- and beta-adrenergic antagonist on epinephrine-induced aggregation and intracellular free calcium concentration in human platelets.
Kimura Y; Okuda H
Biochem Biophys Res Commun; 1994 Jul; 202(2):1069-75. PubMed ID: 7914077
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
